However, the function of DC2 has also been implicated in the activation of CD8+ cytotoxic T cell (TC) responses, specifically in tumor settings, where interferon (IFN)‐stimulated DC2 activate CD8+ T cells by presenting intact tumor‐derived p:MHC I complexes via the process of “MHC‐dressing” [99]. The gene discussed is HLA-C; the disease is neoplasm.